Dimerix Holds Pre-IND Meeting on DMX-200 With FDA
Filed with ASX · · 2 pages · English
In the deck
Earlier from Dimerix
- New Drug Pipeline Candidate DMX-700 & Company Update
- DMX-200 Phase 2 Clinical Study in DKD Completes Recruitment
- DMX-200 Phase 2 Clinical Trial in FSGS Fully Recruited
- DMX-200 Clinical Update
- Dimerix Signs Licence Agreement for Receptor-HIT Technology
Later from Dimerix
- Dimerix Completes $2.5m Placement
- DMX-200 Clinical Trial Update
- Quarterly Commentary & Appendix 4C
- Half Yearly Report and Accounts
- DMX-200 Treatment Continued Under TGA Special Access Scheme
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix